Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,626 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- OncoTree
- BREAST
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02273973 | A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI) | completed | Phase 2 | 334 | Genentech, Inc.INDUSTRY | 22 | May 21, 2018 | clinicaltrials |
| NCT00423917 | Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 36 | Alliance for Clinical Trials in OncologyOTHER | 1 | May 8, 2018 | clinicaltrials |
| NCT01086605 | Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer | completed | Phase 2 | 46 | Alliance for Clinical Trials in OncologyOTHER | 1 | May 8, 2018 | clinicaltrials |
| NCT01091454 | Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 48 | Alliance for Clinical Trials in OncologyOTHER | 1 | May 8, 2018 | clinicaltrials |
| NCT00944047 | Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression | completed | Phase 2 | 32 | University of Kansas Medical CenterOTHER | 1 | Apr 23, 2018 | clinicaltrials |
| NCT00617539 | Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases | completed | Phase 2 | 30 | University of California, San FranciscoOTHER | 1 | Apr 20, 2018 | clinicaltrials |
| NCT02404844 | Trial of BKM120/Tamoxifen-combination in Patients With HR-pos, HER2-neg Breast Cancer(PIKTAM) | completed | Phase 2 | 48 | University Hospital, EssenOTHER | 1 | Apr 20, 2018 | clinicaltrials |
| NCT00834678 | Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer | completed | Phase 1 / Phase 2 | 11 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 17, 2018 | clinicaltrials |
| NCT01042535 | Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 44 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Apr 11, 2018 | clinicaltrials |
| NCT00559845 | A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer | completed | Phase 2 | 56 | Hoffmann-La RocheINDUSTRY | 1 | Apr 9, 2018 | clinicaltrials |
| NCT01642511 | Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Negative(IMSLNB-EBCP) | completed | Phase 2 | 407 | Shandong Cancer Hospital and InstituteOTHER | 1 | Apr 4, 2018 | clinicaltrials |
| NCT00090857 | Letrozole in Preventing Breast Cancer in Postmenopausal Women(WISE) | completed | Phase 2 | 49 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 30, 2018 | clinicaltrials |
| NCT00885755 | A Study of Herceptin (Trastuzumab)and Biomarkers in Patients With HER2-Positive Metastatic Breast Cancer | completed | Phase 2 | 33 | Hoffmann-La RocheINDUSTRY | 4 | Mar 29, 2018 | clinicaltrials |
| NCT01706016 | Local Treatment by Thermic Destruction of Primitive Breast Cancer(LASERBREAST1) | completed | Phase 2 | 16 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Mar 29, 2018 | clinicaltrials |
| NCT02831530 | Randomized Short-term Pre-surgical Study to Assess the Effects of Abemaciclib (LY2835219) in Early Breast Cancer Patients(ABC-POP) | completed | Phase 2 | 101 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Mar 29, 2018 | clinicaltrials |
| NCT01439711 | Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ | completed | Phase 2 | 108 | Alliance for Clinical Trials in OncologyOTHER | 1 | Mar 27, 2018 | clinicaltrials |
| NCT00647582 | Radiation Therapy During and After Lumpectomy in Treating Women With Stage I or Stage II Breast Cancer | completed | Phase 2 | 80 | Mayo ClinicOTHER | 0 | Mar 21, 2018 | clinicaltrials |
| NCT01142778 | A Study of Bevacizumab Added to Trastuzumab Plus Docetaxel in the Neoadjuvant Setting in Participants With Early Stage HER2-Positive Breast Cancer(AVATAXHER) | completed | Phase 2 | 152 | Hoffmann-La RocheINDUSTRY | 1 | Mar 16, 2018 | clinicaltrials |
| NCT00194779 | Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery | completed | Phase 2 | 50 | University of WashingtonOTHER | 1 | Mar 12, 2018 | clinicaltrials |
| NCT00256243 | Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast Cancer | completed | Phase 2 | 48 | Rita Sanghvi, MehtaOTHER | 1 | Mar 2, 2018 | clinicaltrials |
| NCT00867217 | Vitamin D3 for Aromatase Inhibitor Induced Arthralgias(VITAL) | completed | Phase 2 | 160 | Qamar KhanOTHER | 1 | Feb 9, 2018 | clinicaltrials |
| NCT02137083 | A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer | completed | Phase 2 | 22 | Fudan UniversityOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT00303992 | Trastuzumab and Irinotecan in Treating Patients With HER2/Neu Positive Metastatic Breast Cancer | completed | Phase 2 | 9 | University of California, San FranciscoOTHER | 1 | Jan 17, 2018 | clinicaltrials |
| NCT00853996 | Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer | completed | Phase 2 | 25 | University of Kansas Medical CenterOTHER | 1 | Jan 17, 2018 | clinicaltrials |
| NCT02783222 | EFficacy and Impact on Function of Two Different Doses of Nab-paclitaxEl in Elderly With advanCed breasT Cancer(EFFECT) | completed | Phase 2 | 160 | Fondazione Sandro PitiglianiOTHER | 1 | Jan 10, 2018 | clinicaltrials |
| NCT01695226 | Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer | completed | Phase 2 | — | Maastricht University Medical CenterOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT00499122 | NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast Cancer | completed | Phase 2 | 41 | University of MiamiOTHER | 1 | Jan 2, 2018 | clinicaltrials |
| NCT00821964 | Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer | completed | Phase 2 | 15 | University of WashingtonOTHER | 1 | Jan 2, 2018 | clinicaltrials |
| NCT01105650 | Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer | completed | Phase 2 | 13 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT00201760 | Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer | completed | Phase 2 | 10 | Kari KendraOTHER | 1 | Dec 27, 2017 | clinicaltrials |
| NCT00404066 | Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer | completed | Phase 2 | 21 | George Albert FisherOTHER | 1 | Dec 22, 2017 | clinicaltrials |
| NCT00068458 | Survival TRaining for ENhancing Total Health (STRENGTH) | completed | Phase 2 | 39 | Duke UniversityOTHER | 1 | Dec 19, 2017 | clinicaltrials |
| NCT02434367 | The Effect of Walking on Fatigue During Radiotherapy in Breast Cancer Patients 65 and Older(WWE) | completed | Phase 2 | 50 | The West Clinic, MemphisINDUSTRY | 1 | Dec 14, 2017 | clinicaltrials |
| NCT01771666 | Pilot Indocyanine Green Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast Cancer | completed | Phase 2 | 23 | Stanford UniversityOTHER | 1 | Dec 11, 2017 | clinicaltrials |
| NCT00118157 | Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen | completed | Phase 2 | 19 | National Cancer Institute (NCI)NIH | 1 | Dec 4, 2017 | clinicaltrials |
| NCT00656019 | Development of Vitamin D as a Therapy for Breast Cancer - Phase 2 | completed | Phase 2 | 63 | Stanford UniversityOTHER | 1 | Dec 2, 2017 | clinicaltrials |
| NCT00365287 | Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer | completed | Phase 1 / Phase 2 | 148 | Masonic Cancer Center, University of MinnesotaOTHER | 0 | Nov 29, 2017 | clinicaltrials |
| NCT02692742 | Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia(MyeloConcept) | completed | Phase 2 | 137 | Myelo Therapeutics GmbHINDUSTRY | 1 | Nov 24, 2017 | clinicaltrials |
| NCT01669239 | Study of Neoadjuvant Myocet®, Paclitaxel, Pertuzumab, and Trastuzumab in HER2-positive Breast Cancer(Opti-HER) | completed | Phase 2 | 83 | SOLTI Breast Cancer Research GroupOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT01669252 | Pharmacogenomic Study of Neoadjuvant Eribulin for HER2 Non-overexpressing Breast Cancer(NeoEribulin) | completed | Phase 2 | 163 | SOLTI Breast Cancer Research GroupOTHER | 4 | Nov 6, 2017 | clinicaltrials |
| NCT02556632 | Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer(Curcumin-II) | completed | Phase 2 | 191 | Gary MorrowOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT00581256 | A Randomized Comparison of Radiation Therapy Techniques in the Management of Node Positive Breast Cancer | completed | Phase 1 / Phase 2 | 54 | University of Michigan Rogel Cancer CenterOTHER | 1 | Oct 31, 2017 | clinicaltrials |
| NCT01307891 | Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer | completed | Phase 2 | 64 | University of Alabama at BirminghamOTHER | 1 | Oct 26, 2017 | clinicaltrials |
| NCT02338245 | Study of ASLAN001 in Combination With Capecitabine in MBC That Has Failed on Prior Trastuzumab | completed | Phase 2 | 200 | ASLAN PharmaceuticalsOTHER | 7 | Oct 17, 2017 | clinicaltrials |
| NCT00563953 | Caelyx as Primary Treatment for Patients With Breast Cancer and a History of Heart Disease and/or Age Over 65 Years(CAPRICE) | completed | Phase 2 | 50 | SOLTI Breast Cancer Research GroupOTHER | 1 | Oct 12, 2017 | clinicaltrials |
| NCT00859651 | Vitamin D in Postmenopausal Women at High Risk for Breast Cancer | completed | Phase 2 | 20 | Columbia UniversityOTHER | 1 | Sep 27, 2017 | clinicaltrials |
| NCT00676793 | A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression | completed | Phase 2 | 32 | Louisiana State University Health Sciences Center ShreveportOTHER | 1 | Sep 21, 2017 | clinicaltrials |
| NCT00654836 | Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer | completed | Phase 2 | 32 | Loyola UniversityOTHER | 1 | Sep 14, 2017 | clinicaltrials |
| NCT01688609 | Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast Cancer | completed | Phase 2 | 18 | National Cancer Institute (NCI)NIH | 2 | Sep 11, 2017 | clinicaltrials |
| NCT00535418 | Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers | completed | Phase 2 / Phase 3 | 35 | Novartis PharmaceuticalsINDUSTRY | 0 | Sep 5, 2017 | clinicaltrials |
Data updated 24 days agoSource updated May 21, 2018source: clinicaltrials